Rafferty Asset Management
CGEM icon

Rafferty Asset Management’s Cullinan Oncology CGEM Stock Holding History

Rafferty Asset Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$987K Buy
69,485
+7,814
+13% +$100K ﹤0.01% 777
2025
Q4 		$638K Buy
61,671
+20,942
+51% +$189K ﹤0.01% 874
2025
Q3 		$242K Buy
40,729
+1,503
+4% +$11K ﹤0.01% 1038
2025
Q2 		$295K Sell
39,226
-15,716
-29% -$126K ﹤0.01% 984
2025
Q1 		$416K Sell
54,942
-34,716
-39% -$333K ﹤0.01% 906
2024
Q4 		$1.09M Sell
89,658
-25,012
-22% -$360K ﹤0.01% 774
2024
Q3 		$1.92M Buy
114,670
+10,019
+10% +$178K 0.01% 646
2024
Q2 		$1.83M Buy
104,651
+7,596
+8% +$162K 0.01% 672
2024
Q1 		$1.65M Buy
+97,055
New +$1.5M 0.01% 733
2022
Q2 		– Sell
-55,152
Closed -$577K – 1151
2022
Q1 		$577K Sell
55,152
-15,987
-22% -$216K ﹤0.01% 928
2021
Q4 		$1.1M Buy
+71,139
New +$1.42M 0.01% 827

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return